You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
倩碧控股(08367.HK)簽訂備忘錄,計劃3年內集資3億以發展自動售藥機項目
格隆匯 05-31 21:01

格隆匯5月31日丨倩碧控股(08367.HK)公佈,公司於2021年5月31日與開封正修福來醫藥科技有限公司(合作方)就擬議合作訂立諒解備忘錄。

合作方主要於中國從事名為"二十四小時未來藥房藥機項目"的自動售藥機銷售藥物業務。該自動售藥機為24小時自助便民藥櫃,而合作方計劃透過於國內各地安裝和營運該自動售藥機和提供相關配套服務和設施,實現一站式綜合醫療大健康生態,為國內醫院及藥房分擔日益上升的醫療需求,改善全國醫療環境。據董事經作出一切合理查詢後所知及確信,合作方及其最終實益擁有人為獨立於公司及其關連人士的第三方。

根據諒解備忘錄,公司與合作方應合作在中國推動名為"二十四小時未來藥房藥機項目"的自動售藥機銷售藥物業務,並計劃於3年內集資人民幣3億以發展自動售藥機項目。公司與合作方將進一步協商訂立擬議合作的細節並簽署正式協議。

除合作方須遵守(i)有關的適用法律和規定和(ii)有關諒解備忘錄相關事宜的保密責任外,諒解備忘錄並未就擬議合作對雙方訂立具有法律約束力的義務。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account